These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28109307)

  • 21. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis.
    Chang YC; Su CY; Chen MH; Chen WS; Chen CL; Hsiao M
    Mol Cancer; 2017 Aug; 16(1):135. PubMed ID: 28784136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of DC-SIGNR in the primary trophoblast cells and its significance].
    Zhang Q; Li JN; Linag ZQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):628-30. PubMed ID: 20108443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.
    Simmons G; Reeves JD; Grogan CC; Vandenberghe LH; Baribaud F; Whitbeck JC; Burke E; Buchmeier MJ; Soilleux EJ; Riley JL; Doms RW; Bates P; Pöhlmann S
    Virology; 2003 Jan; 305(1):115-23. PubMed ID: 12504546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-type lectin LSECtin interacts with DC-SIGNR and is involved in hepatitis C virus binding.
    Li Y; Hao B; Kuai X; Xing G; Yang J; Chen J; Tang L; Zhang L; He F
    Mol Cell Biochem; 2009 Jul; 327(1-2):183-90. PubMed ID: 19234677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking hepatic metastases of colon cancer cells using an shRNA against Rac1 delivered by activatable cell-penetrating peptide.
    Bao Y; Guo H; Lu Y; Feng W; Sun X; Tang C; Wang X; Shen M
    Oncotarget; 2016 Nov; 7(47):77183-77195. PubMed ID: 27791203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection.
    Nattermann J; Ahlenstiel G; Berg T; Feldmann G; Nischalke HD; Müller T; Rockstroh J; Woitas R; Sauerbruch T; Spengler U
    J Viral Hepat; 2006 Jan; 13(1):42-6. PubMed ID: 16364081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection.
    Wichukchinda N; Kitamura Y; Rojanawiwat A; Nakayama EE; Song H; Pathipvanich P; Auwanit W; Sawanpanyalert P; Iwamoto A; Shioda T; Ariyoshi K
    AIDS Res Hum Retroviruses; 2007 May; 23(5):686-92. PubMed ID: 17530994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.
    Kargl J; Andersen L; Hasenöhrl C; Feuersinger D; Stančić A; Fauland A; Magnes C; El-Heliebi A; Lax S; Uranitsch S; Haybaeck J; Heinemann A; Schicho R
    Br J Pharmacol; 2016 Jan; 173(1):142-54. PubMed ID: 26436760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of DC-SIGN and DC-SIGNR repeat region variations.
    Liu H; Zhu T
    Methods Mol Biol; 2005; 304():471-81. PubMed ID: 16061998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
    Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
    Shin HN; Moon HH; Ku JL
    Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability.
    Bresalier RS; Hujanen ES; Raper SE; Roll FJ; Itzkowitz SH; Martin GR; Kim YS
    Cancer Res; 1987 Mar; 47(5):1398-406. PubMed ID: 3028609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An RNA aptamer that binds carcinoembryonic antigen inhibits hepatic metastasis of colon cancer cells in mice.
    Lee YJ; Han SR; Kim NY; Lee SH; Jeong JS; Lee SW
    Gastroenterology; 2012 Jul; 143(1):155-65.e8. PubMed ID: 22465431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All but the shortest polymorphic forms of the viral receptor DC-SIGNR assemble into stable homo- and heterotetramers.
    Guo Y; Atkinson CE; Taylor ME; Drickamer K
    J Biol Chem; 2006 Jun; 281(24):16794-8. PubMed ID: 16621794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A; Gold LI; Wang J; Cohen A; Friedman E
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.
    Barderas R; Mendes M; Torres S; Bartolomé RA; López-Lucendo M; Villar-Vázquez R; Peláez-García A; Fuente E; Bonilla F; Casal JI
    Mol Cell Proteomics; 2013 Jun; 12(6):1602-20. PubMed ID: 23443137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.
    Ludwig IS; Lekkerkerker AN; Depla E; Bosman F; Musters RJ; Depraetere S; van Kooyk Y; Geijtenbeek TB
    J Virol; 2004 Aug; 78(15):8322-32. PubMed ID: 15254204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protease allergen Der p 1 cleaves cell surface DC-SIGN and DC-SIGNR: experimental analysis of in silico substrate identification and implications in allergic responses.
    Furmonaviciene R; Ghaemmaghami AM; Boyd SE; Jones NS; Bailey K; Willis AC; Sewell HF; Mitchell DA; Shakib F
    Clin Exp Allergy; 2007 Feb; 37(2):231-42. PubMed ID: 17250696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.
    Guo Y; Feinberg H; Conroy E; Mitchell DA; Alvarez R; Blixt O; Taylor ME; Weis WI; Drickamer K
    Nat Struct Mol Biol; 2004 Jul; 11(7):591-8. PubMed ID: 15195147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.